Jürgen Ramharter
Boehringer Ingelheim (Germany)(DE)Boehringer Ingelheim (Austria)(AT)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Melanoma and MAPK Pathways, Alkaloids: synthesis and pharmacology, Cell Image Analysis Techniques, Medicinal Plant Extracts Effects
Most-Cited Works
- → BI-3406, a Potent and Selective SOS1–KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK Inhibition(2020)393 cited
- → Discovery of Novel Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one Compounds as Chemically Stable and Orally Active Inhibitors of the MDM2–p53 Interaction(2016)119 cited
- → Synthesis of the Lycopodium Alkaloid (+)-Lycoflexine(2010)99 cited
- → One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS(2021)61 cited
- → Valerenic acid derivatives as novel subunit‐selective GABAAreceptor ligands –in vitroandin vivocharacterization(2010)49 cited
- → Abstract 1091: BI-3406 and BI 1701963: Potent and selective SOS1::KRAS inhibitors induce regressions in combination with MEK inhibitors or irinotecan(2020)45 cited
- → Total Synthesis of Valerenic Acid, a Potent GABAAReceptor Modulator(2009)37 cited
- → Targeted Synthesis of Complex Spiro[3H‐indole‐3,2′‐pyrrolidin]‐2(1H)‐ones by Intramolecular Cyclization of Azomethine Ylides: Highly Potent MDM2–p53 Inhibitors(2018)28 cited
- → opnMe.com: a digital initiative for sharing tools with the biomedical research community(2022)27 cited
- → Efficient and Scalable One-Pot Synthesis of 2,4-Dienols from Cycloalkenones: Optimized Total Synthesis of Valerenic Acid(2011)18 cited